Abstract Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many
human disorders. The persistence of these viral genomes in all malignant cells, yet with the …

EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

The association between Epstein-Barr virus (EBV) and a large number of benign and
malignant diseases is unique among DNA viruses. Within infected tissues, proteins that are …

It is estimated that viral infections contribute to 15–20% of all human cancers. As obligatory
intracellular parasites, viruses encode proteins that reprogram host cellular signaling …

Epstein–Barr virus (EBV) is consistently detected in nasopharyngeal carcinoma (NPC) from
regions of high and low incidence. EBV DNA within the tumor is homogeneous with regard …

Latency is a state of cryptic viral infection associated with genomic persistence and highly
restricted gene expression. Its hallmark is reversibility: under appropriate circumstances …

A comprehensive mapping of interactions among Epstein–Barr virus (EBV) proteins and
interactions of EBV proteins with human proteins should provide specific hypotheses and a …

Gammaherpesviruses are lymphotropic viruses that are associated with the development of
lymphoproliferative diseases, lymphomas, as well as other nonlymphoid cancers. Most …

The familial breast–ovarian tumor suppressor gene product BRCA1 was found to be a
component of the RNA polymerase II holoenzyme by several criteria. BRCA1 was found to …

Epstein–Barr virus (EBV; human herpesvirus 4; HHV‐4) and Kaposi sarcoma‐associated
herpesvirus (KSHV; human herpesvirus 8; HHV‐8) are human gammaherpesviruses that …